Camlin Fine Sciences Analysis

dividend

Pros

Cons

• Unable to calculate sustainability of dividends as Camlin Fine Sciences has not reported any payouts.
• Unable to evaluate Camlin Fine Sciences's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
• Unable to evaluate Camlin Fine Sciences's dividend against the top 25% market benchmark as the company has not reported any payouts.

future

Pros

• Camlin Fine Sciences's earnings growth is expected to exceed the India market average.
• Camlin Fine Sciences's earnings growth is expected to exceed the low risk savings rate of 7.2%.
• Camlin Fine Sciences's earnings are expected to exceed the low risk growth rate next year.
• Camlin Fine Sciences's revenue growth is expected to exceed the India market average.

Cons

• Camlin Fine Sciences's earnings are expected to grow by 18.9% yearly, however this is not considered high growth (20% yearly).
• Camlin Fine Sciences's revenue is expected to grow by 11.6% yearly, however this is not considered high growth (20% yearly).

health

Pros

• Camlin Fine Sciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
• Camlin Fine Sciences is profitable, therefore cash runway is not a concern.
• Camlin Fine Sciences is profitable, therefore cash runway is not a concern.
• Debt is covered by short term assets, assets are 1.3x debt.
• Camlin Fine Sciences's cash and other short term assets cover its long term commitments.
• The level of debt compared to net worth has been reduced over the past 5 years (122.9% vs 102.4% today).
• Interest payments on debt are well covered by earnings (EBIT is 3.8x coverage).

Cons

• Debt is not well covered by operating cash flow (9.1%, less than 20% of total debt).
• Camlin Fine Sciences's level of debt (102.4%) compared to net worth is high (greater than 40%).
• High level of physical assets or inventory.

management

Pros

• The tenure for the Camlin Fine Sciences board of directors is about average.
• Ashish's compensation has been consistent with company performance over the past year, both up more than 20%.
• The tenure for the Camlin Fine Sciences management team is about average.

Cons

• Ashish's remuneration is higher than average for companies of similar size in India.

misc

Pros

Cons

• Camlin Fine Sciences is covered by less than 3 analysts.
• Camlin Fine Sciences has significant price volatility in the past 3 months.

past

Pros

Cons

• Camlin Fine Sciences has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
• Camlin Fine Sciences's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
• Camlin Fine Sciences used its assets less efficiently than the IN Chemicals industry average last year based on Return on Assets.
• Camlin Fine Sciences's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
• Camlin Fine Sciences has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
• Camlin Fine Sciences has become profitable in the last year making it difficult to compare the IN Chemicals industry average.

value

Pros

• Camlin Fine Sciences is good value based on expected growth next year.
• 532834 matched the India Market (-14.5%) over the past year.
• BSE:532834 is up 9.1% outperforming the Chemicals industry which returned 6.9% over the past month.
• BSE:532834 is up 9.1% outperforming the market in India which returned 8% over the past month.

Cons

• Camlin Fine Sciences is overvalued based on assets compared to the IN Chemicals industry average.
• Camlin Fine Sciences is overvalued based on earnings compared to the IN Chemicals industry average.
• Camlin Fine Sciences is overvalued based on earnings compared to the India market.
• 532834 underperformed the Chemicals industry which returned 2.2% over the past year.